Onyx HealthcareROCO:6569 75 Gross Margin % is 37.10% as of Dec. 2025, which is 9% above its 10-year median of 34.00. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Onyx Healthcare ranks worse than 59.37% on this metric.
The historical rank and industry rank for Onyx Healthcare's Gross Margin % or its related term are showing as below:
ROCO:6569'
s Gross Margin % Range Over the Past 10 Years
Min: 29.51 Med: 34 Max: 43.52
Current: 33.05
During the past 13 years, the highestGross Margin % of Onyx Healthcare was 43.52%. The lowest was 29.51%. And the median was 34.00%.
ROCO:6569's Gross Margin % is ranked worse than 59.37% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.01
vs ROCO:6569: 33.05
Onyx Healthcare had a gross margin of 37.10% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Onyx Healthcare was 1.80% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Onyx Healthcare had a gross margin of 37.10% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Onyx Healthcare Gross Margin % Related Terms
Onyx Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Onyx Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6569 vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, Onyx Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Onyx Healthcare (ROCO:6569) has a Gross Margin % of 37.10% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Onyx Healthcare and its competitors. This is near median its historical median of 34.00. Over the past decade, Onyx Healthcare's Gross Margin % has ranged from 29.51 to 43.52. According to the industry distribution chart, Onyx Healthcare ranks #374 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 59.4%.
Is Onyx Healthcare's Gross Margin % too high?
Onyx Healthcare's current Gross Margin % of 37.10% is near median its 10-year median of 34.00. Over the past 10 years, this metric has ranged from a low of 29.51 to a high of 43.52. The Healthcare Providers & Services industry median Gross Margin % is 40.01. Onyx Healthcare's value of 37.10% is 7.3% below this industry median. Based on the distribution chart, Onyx Healthcare ranks #374 out of 630 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #374 out of 630 companies for Gross Margin %. This places Onyx Healthcare in the lower half of its industry. The industry median Gross Margin % is 40.01. Onyx Healthcare's value of 37.10% is 7.3% below this benchmark. Historically, Onyx Healthcare's own Gross Margin % has ranged from 29.51 to 43.52 over the past decade. While the company's 10-year median is 34.00 vs. the industry median of 40.01, Onyx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.01, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Gross Margin % of 37.10% is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Gross Margin % is 37.10%, which is near median its own 10-year median of 34.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Gross Margin % is 37.10%, which is near median its 10-year median of 34.00 and 7.3% below the Healthcare Providers & Services industry median of 40.01. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Gross Margin % is 37.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
Gross Margin %: 37.10% (near median its 10-year median of 34.00)
GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
Industry Position: 7.3% below the Healthcare Providers & Services median (#374 of 630)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score
Get the complete analysis for ROCO:6569
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
